Evaluation of the Contraceptive Efficacy and Safety of a New Concentration of an Antiandrogenic Progestogen Combined With a Reduced-Dose Estrogen (LUNA)

NCT07714616 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1600

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: Cyproterone Acetate 2 mg and Ethinyl Estradiol 0.02 mg

Sponsor

Eurofarma Laboratorios S.A.